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Cardiovascular disease (CVD) is a leading cause of 
morbidity and mortality worldwide, partly owing 
to the increasing prevalence of major risk factors for 
CVD, such as hypertension, diabetes mellitus and 
chronic kidney disease. What constitutes CVD has 
undergone substantial refinement owing to advances 
in biomarker discovery, analytical chemistry and 
imaging physics. By contrast, current markers to iden-
tify and stratify CVD lack similar precision. These bio-
markers are coarse (such as sex and smoking), reflect 
established target- organ damage (for example, serum 
creatinine levels and albuminuria) and are unable to 
discriminate between CVD outcomes (such as blood 
pressure and LDL- cholesterol levels). Additionally, the 
capacity of these measures to track the risk of CVD 
over time or in response to treatment remains poorly 
defined. Therefore, currently established metrics of 
the risk of CVD, although useful at a population level, 
cannot be used to quantify the risk accurately for 
an individual.
Alterations in the structure and function of micro-
vessels (luminal diameter <300 µm) are a unifying feature 
in the initiation and progression of CVD. The eye pro-
vides a unique window to the microvasculature, and reti-
nal imaging offers a noninvasive method of detecting 
such alterations that might allow earlier identification 
and targeting of at- risk patients.
The eye has fascinated artists and scientists for cen-
turies. A future in which retinal scanning is the most 
reliable biometric means of verifying an individual’s 
identity (and linked history) is closer than many might 
be comfortable with. These retinal ‘fingerprints’ rely 
on the recognition of the unique branching patterns of 
the retinal vasculature. By contrast, pupillary recogni-
tion versions of this technology analyse an individu-
al’s corrugations of the iris — the specialized anterior 
extension of the choroid vascular layer. The vascula-
ture of the eye is, therefore, truly individual and has the 
potential to yield granular data about burden and risk 
of CVD.
The eye and CVD
Nearly 80 years ago, the presence of retinopathy was 
noted to confer an increased risk of adverse outcomes 
in patients with hypertension. Modern retinal imag-
ing, predominantly using fundus photography, has 
sought to identify, quantify and link retinal microvas-
cular changes with traditional CVD risk factors and 
outcomes in different populations. Measures of retinal 
arteriolar and venular calibre predict the development 
of hypertension, diabetes and renal impairment as well 
as CVD complications in patients with coronary artery 
disease, cerebrovascular disease and diabetes1. These 
metrics also provide incremental value to current CVD 
risk- stratification tools and have particular utility in pre-
dicting outcomes of coronary artery disease in women1. 
Retinal vascular geometry and network complexity 
have been analysed to identify subtle or evolving vessel 
pathology, showing associations with prevalent CVD 
risk factors and events.
Barriers to the translation of retinal imaging to clini-
cal practice as part of CVD risk assessment, such as lack 
of automated metrics, magnification or focusing errors 
and the need for mydriasis (dilatation of the pupil) for 
static vessel analysis, have been overcome with advances 
in imaging hardware and analysis software. The ease of 
imaging the retinal circulation is an important strength 
but misrepresents the true depth of the eye’s micro-
vasculature. The use of novel imaging modalities, such 
as retinal optical coherence tomography (OCT), to target 
deeper retinal vascular networks, which might reflect 
microvascular disease earlier and more accurately, can 
overcome this challenge.
Deep imaging with retinal OCT
Retinal OCT provides rapid, ultra- high resolution, 
tomographic (cross- sectional) imaging of the retina in 
near- histological detail. Identification and automated 
segmentation of individual retinal layers with the use 
of OCT has provided novel insights into the role of 
the chorioretinal microvasculature in the pathogenesis 
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of age- related macular degeneration, diabetic retin-
opathy and glaucoma. OCT also has the potential to 
image the previously inaccessible choroid. This layer 
contains the choroidal circulation, which receives 
~80% of retinal blood flow and provides passive oxy-
genation of important visual apparatus, including the 
retinal pigment epithelium, photoreceptors and the 
avascular fovea. The cross- sectional nature of OCT 
imaging allows vessel wall and/or lumen analyses 
but OCT also acquires en- face fundus images for 
vessel calibre assessment to complement choroidal 
imaging. Therefore, OCT captures the entire chorio-
retinal microcirculation and its dependent tissue in a 
single platform.
OCT has revealed vessel remodelling and chorio-
retinal thinning in clinical hypertension, diabetes and 
chronic kidney disease. The highly vascular nature of 
the choroid suggests that this thinning probably repre-
sents changes in microvascular structure or function. We 
have found that choroidal thinning was more severe in 
individuals with a lower glomerular filtration rate and 
greater proteinuria, both strongly associated with micro-
vascular dysfunction2. Also, those with a thinner choroid 
had higher serum levels of endothelin 1 and asymmet-
ric dimethylarginine (an endogenous inhibitor of nitric 
oxide synthesis), further supporting this association. 
Importantly, we linked chorio retinal thinning with renal 
histological vascular injury, demonstrating that OCT- 
derived metrics can inform on changes in distant tar-
get organs2. Choroidal thinning is also seen in patients 
with overt CVD, but no data currently exist on its utility 
for profiling the risk of CVD compared with standard 
clinical measurements.
OCT angiography combines structural and func-
tional imaging by analysing the changing variance over 
multiple scans in the light speckle created by erythro-
cyte flow. This approach generates a contrast- free reti-
nal angiogram down to the capillary level and surrogate 
indices of perfusion. Data are emerging showing reduced 
retinal vessel density and perfusion in individuals with 
CVD risk factors as well as in those with overt CVD. One 
study found correlations between the severity of retinal 
capillary rarefaction and greater risk of CVD, assessed 
using the AHA and Global Registry for Acute Coronary 
Events (GRACE) scoring systems3. Of note, OCT angi-
ography is susceptible to movement artefact degradation 
and lacks true perfusion indices. The latter problem can 
be overcome with the addition of Doppler OCT, which 
detects the frequency shift of back- scattered light from 
erythrocyte flow, allowing determination of blood- flow 
velocity together with vessel dimensions.
Preclinical OCT allows simultaneous, noninvasive 
longitudinal imaging of the eye in disease models and 
might provide novel insights into underlying mecha-
nisms. We have used OCT to explore the links between 
the eye and the kidney and have shown that mice with 
hypertension alone had no choroidal thinning, whereas 
mice with matched hypertension levels and additional 
renal injury developed significant choroidal thinning2. 
These studies are important to advance our under-
standing of the retinal vascular changes associated with 
systemic vascular disease.
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Fig. 1 | Retinal fingerprints for precision profiling of the risk of cardiovascular disease. Multimodal imaging enables 
the comprehensive assessment of the retinal microvasculature to define the risk of cardiovascular disease (CVD). Changes 
in vessel calibre and network geometry observed by retinal photography are strongly associated with CVD risk factors and 
outcomes. Novel retinal metrics associated with risk of CVD, such as chorioretinal thinning and capillary rarefaction, 
are emerging following the advent of optical coherence tomography (OCT) and its contrast- free angiography platform. 
Integration of these high- fidelity imaging data with machine learning analysis and neural network formation represents 
the next critical phase in developing retinal imaging as a means of providing individualized assessment of the risk of CVD. 
CKD, chronic kidney disease.
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Deep learning and retinal imaging
Deep learning is an extension of machine learning 
whereby predictive patterns are learnt and refined by 
the machine itself, using an algorithm developed from 
a large example dataset, such as a bank of graded retinal 
images. Work in this field has used retinal photographs 
and clinical data from >280,000 patients to train an algo-
rithm to predict a range of risk factors for CVD from 
two separate banks of retinal photographs, totalling 
~13,000 patients4. The algorithm had impressive accu-
racy for predicting sex (area under the curve (AUC) 0.97), 
smoking status (AUC 0.71), age (mean absolute error 
~3 years) and systolic blood pressure (mean absolute 
error ~11 mmHg)4. For predicting incident CVD, the 
algorithm offered little improvement over a conven-
tional CVD risk- scoring tool, but encouragingly showed 
equivalent power. A similar approach involving OCT 
images has been successfully used to triage and diagnose 
sight- threatening retinal diseases5.
Future challenges
Important questions remain about the role of retinal 
imaging in CVD. Do retinal vessel metrics offer suffi-
cient incremental value to clinicians to warrant their 
inclusion into CVD risk profiling? Data suggest that 
~10% of patients are reclassified when adding retinal 
metrics to current tools1. Whether acting on this infor-
mation translates into meaningful differences in patient 
outcomes remains unclear. Similarly, whether retinal 
vascular metrics are modifiable in a manner that ena-
bles them to be used as dynamic markers of risk and/or 
treatment response remains unclear. Addressing these 
questions will require well- designed preclinical and clin-
ical studies, with longitudinal imaging and data linkage, 
which are currently available in only a few countries. 
The continued expansion of analytical technology to 
maximize the yield from increasingly complex retinal 
imaging data is an exciting field in itself.
Conclusions
The eye is a well- defined target organ whose microves-
sel network can now be precisely mapped, measured 
and tracked. Quantitative vessel analysis of retinal pho-
tographs has provided a strong rationale for using ret-
inal fingerprints to report and stratify the risk of CVD 
(Fig. 1). Novel modalities, such as OCT, have undergone 
rapid clinical expansion and have shown potential in 
detecting retinal microvascular changes that are asso-
ciated with surrogate markers of increased risk of CVD. 
OCT devices are now commonplace in many opticians, 
and so the very real potential exists for these devices 
to be used for CVD risk assessment in the wider com-
munity. Advances in data analysis might soon enable 
clinicians to generate individualized chorioretinal risk 
scores to identify patients at risk of CVD on the basis of 
precise, segmented OCT metrics. Combining this deep 
imaging with deep learning represents the next frontier 
in defining what the eye can reveal about cardiovascular 
health and disease.
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